Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
RGX-019 is a monoclonal antibody that selectively targets Mertk for internalization and degradation, leading to inhibition of cancer cell growth (AACR Annual Meeting 2019, Abstract LB-277).
|DrugClasses||MERTK Antibody 1|
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|